Evaluation of Nuclear Factor- B, Urokinase-Type Plasminogen Activator, and HBx and Their Clinicopathological Significance in Hepatocellular Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-03-0574
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Elevated Levels of Serum Urokinase Plasminogen Activator Predict Poor Prognosis in Hepatocellular Carcinoma After Resection

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Biological Significance of the Expression of Urokinase-Type Plasminogen Activator Receptors (uPARs) in Brain Tumors

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
1999English

Interaction of Single-Chain Urokinase and Plasminogen Activator Inhibitor Type 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Urokinase-Type Plasminogen Activator (PLAU; uPA); Thrombin (F2)

Science-Business eXchange
2010English

Multiple Nuclear Factors Interact With Promoter Sequences of the Urokinase-Type Plasminogen Activator Gene

Nucleic Acids Research
Genetics
1988English

Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms

Gut
Gastroenterology
1998English

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea

Medicina
Medicine
2020English

Ligand Binding Regions in the Receptor for Urokinase-Type Plasminogen Activator

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Accessibility of Receptor-Bound Urokinase to Type-1 Plasminogen Activator Inhibitor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy